User:DrPlantGenomics/sandbox8
Elizabeth L. Hartland | |
---|---|
Education | University of Melbourne |
Occupation | Immunologist |
Employer | Monash University |
Known for | Immunology |
Title | Professor |
Website | https://research.monash.edu/en/persons/elizabeth-hartland |
Elizabeth L. Hartland or Elizabeth Louise Hartland (born ) is a microbiologist and immunologist, and Eureka prize judge.[1] She was awarded an Order of Australia in 2024,[2] for service to "medical research, particularly microbiology, and to tertiary education".[3] She is CEO and Director of the Hudson Institute of Medical Research within Monash University.[4]
Education and career
[edit]Hartland received a Bachelor of Science (Hons), in 1990, a PhD in Microbiology and Immunology in 1996. She was then awarded a Bachelor of Arts from the University of Melbourne in 1997, and a Graduate Certificate in Higher Education in 2004, from Monash University.[5]
Hartland then worked at the Department of Biochemistry at Imperial College, at London, with a Royal Society/NHMCR Howard Florey Fellowship. She was one of the first ARC Future Fellows at the University of Melbourne. Hartland was the Head of Department for the Department of Microbiology and Immunology at the University of Melbourne. She then was employed as the Deputy Director of the Doherty Institute. Hartland was also the president of the Association of Australian Medical Research Institutes (AAMRI).[6] As at 2024, Hartland is the Director of the Hudson Institute of Medical Research.[7]
Hartland's research interests include pathogenesis and infections which are involved with Gram-negative pathogens. She also has research interests in immune evasion and bacterial colonization. Hartland's main areas of expertise include cell intrinsic immunity, intenstinal bacterial pathogens and human microbiota and immune responses.[8]
Hartland has an oration at the Victorian Infection and Immunity Network named after her, where the winner receives prize money, and delivers a speech at the Lorne conference.[9] Hartland is also the chair of the Victorian Premier's award, for the selection panel of Health and Medical Research.[10]
Publications
[edit]Hartland has over 165 publications, with an H-index of 58 and over 10,000 citations as at July 2024, according to Google Scholar.[11]
- Marshall, S. A., Young, R. B., Lewis, J. M., Rutten, E. L., Gould, J., Barlow, C. K., Giogha, C., Marcelino, V. R., Fields, N., Schittenhelm, R. B., Hartland, E. L., Scott, N. E., Forster, S. C. & Gulliver, E. L., (2023) The broccoli-derived antioxidant sulforaphane changes the growth of gastrointestinal microbiota, allowing for the production of anti-inflammatory metabolites,Journal of Functional Foods. 107,105645,ISSN 1756-4646.[12]
- Giogha C, Scott NE, Wong Fok Lung T, Pollock GL, Harper M, Goddard-Borger ED, et al. (2021) NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector. PLoS Pathog 17(6): e1009658.[13]
- Srikhanta, Y.N., Gorrell, R.J., Power, P.M. et al. (2017) Methylomic and phenotypic analysis of the ModH5 phasevarion of Helicobacter pylori . Sci Rep 7, 16140.[14]
- Hartland, E. Bacterial pathogenesis: (2017) Legionella phosphoinositide tailoring. Nat Microbiol 2, 17013. [15]
Awards
[edit]- 2024 - King's Birthday awards.[16]
- 2024 - NHMRC - Investigator grant.[17]
- 2015 - NHMRC - Project grant.[18]
- 2014 - Eureka prize finalist.[19]
External links
[edit]References
[edit]- ^ Eureka prize. "Eureka Prizes Judges". The Australian Museum. Retrieved 2024-07-23.
- ^ "Hudson CEO honoured for services to medical research". Hudson Institute of Medical Research. 2024-06-09. Retrieved 2024-07-23.
- ^ "AAMRI news".
- ^ "NHMRC".
- ^ "ORCID". orcid.org. Retrieved 2024-07-23.
- ^ Smith, Paul N.; Gill, David R.J.; McAuliffe, Michael J.; McDougall, Catherine; Stoney, James D.; Vertullo, Christopher J.; Wall, Christopher J.; Corfield, Sophia; Cashman, Kara (2023-10-01). Mortality Following Primary Hip and Knee Arthroplasty Supplementary Report (Report). Australian Orthopaedic Association.
- ^ News, Mirage. "Professor Elizabeth Hartland new Chair of VicAAMRI". Mirage News. Retrieved 2024-07-23.
{{cite web}}
:|last=
has generic name (help) - ^ "Elizabeth Hartland". Monash University. Retrieved 2024-07-23.
- ^ "The Hartland Oration 2023 | News | VIIN". Victorian Infection and Immunity Network. Retrieved 2024-07-23.
- ^ "Sirsidynix".
- ^ "Elizabeth Hartland". scholar.google.com.au. Retrieved 2024-07-23.
- ^ Marshall, Sarah A.; Young, Remy B.; Lewis, Jessica M.; Rutten, Emily L.; Gould, Jodee; Barlow, Christopher K.; Giogha, Cristina; Marcelino, Vanessa R.; Fields, Neville; Schittenhelm, Ralf B.; Hartland, Elizabeth L.; Scott, Nichollas E.; Forster, Samuel C.; Gulliver, Emily L. (2023-08-01). "The broccoli-derived antioxidant sulforaphane changes the growth of gastrointestinal microbiota, allowing for the production of anti-inflammatory metabolites". Journal of Functional Foods. 107: 105645. doi:10.1016/j.jff.2023.105645. ISSN 1756-4646.
- ^ Giogha, Cristina; Scott, Nichollas E.; Lung, Tania Wong Fok; Pollock, Georgina L.; Harper, Marina; Goddard-Borger, Ethan D.; Pearson, Jaclyn S.; Hartland, Elizabeth L. (2021-06-16). "NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector". PLOS Pathogens. 17 (6): e1009658. doi:10.1371/journal.ppat.1009658. ISSN 1553-7374. PMC 8238200. PMID 34133469.
{{cite journal}}
: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link) - ^ Srikhanta, Yogitha N.; Gorrell, Rebecca J.; Power, Peter M.; Tsyganov, Kirill; Boitano, Matthew; Clark, Tyson A.; Korlach, Jonas; Hartland, Elizabeth L.; Jennings, Michael P.; Kwok, Terry (2017-11-23). "Methylomic and phenotypic analysis of the ModH5 phasevarion of Helicobacter pylori". Scientific Reports. 7 (1): 16140. doi:10.1038/s41598-017-15721-x. ISSN 2045-2322.
- ^ Srikhanta, Yogitha N.; Gorrell, Rebecca J.; Power, Peter M.; Tsyganov, Kirill; Boitano, Matthew; Clark, Tyson A.; Korlach, Jonas; Hartland, Elizabeth L.; Jennings, Michael P.; Kwok, Terry (2017-11-23). "Methylomic and phenotypic analysis of the ModH5 phasevarion of Helicobacter pylori". Scientific Reports. 7 (1): 16140. doi:10.1038/s41598-017-15721-x. ISSN 2045-2322.
- ^ "AAMRI".
- ^ "Elizabeth Hartland - Director & CEO at Hudson Institute of Medical Research". THE ORG. Retrieved 2024-07-23.
- ^ "Biomedical sciences".
- ^ Eureka prize news. "Australian Infectious Diseases Research Centre Eureka Prize". The Australian Museum Eureka prize. Retrieved 2024-07-23.